Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pediatric Reviews
  4. Fast Track Articles
  5. Fast Track Article
image of Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection

Abstract

The novel Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, created a need for evidence-based guidelines for the evaluation, management, and follow-up after infection. Data have become rapidly available, creating a challenge for medical providers to stay abreast of the ever-evolving recommendations. This document, written collaboratively by pediatric cardiovascular experts, pediatricians, and sports medicine specialists, is focused on SARS-CoV-2-related pediatric cardiac manifestations. It aims to provide a systemic review of high-yield literature related to all cardiovascular entities as a tool for primary pediatric clinicians to utilize as they consider the cardiac consequences of acute SARS-CoV-2 infection, MIS-C, vaccine-related myocarditis, return-to-play, and long COVID-19 syndrome.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963314978240923110844
2024-10-02
2025-02-17

  • From This Site

    /content/journals/cpr/10.2174/0115733963314978240923110844
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. World Health Organization Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, 25 January 2020. World Health Organization 2020
    [Google Scholar]
  2. Centers for Disease Control Prevention Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). 2020 Available from: https://stacks.cdc.gov/view/cdc/89980
  3. European Centre for Disease Prevention Control Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19. ECDC 2020
    [Google Scholar]
  4. Bhimraj A. Infectious diseases society of America guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 2020
    [Google Scholar]
  5. COVID-19 Treatment Guidelines Panel Coronavirus Disease 2019 (COVID-19) Treatment Guidelines 2019 Available from: https://www.covid19treatmentguidelines.nih.gov/
    [Google Scholar]
  6. National Center for Biotechnology Information (US) National Center for Biotechnology Information (US). 2024 Available from: https://pubmed.ncbi.nlm.nih.gov/?term=pediatric%20covid&filter=years.2018-2023&sort=pubdate&sort_order=asc&timeline=expanded
  7. Lu X. Zhang L. Du H. Zhang J. Li Y.Y. Qu J. Zhang W. Wang Y. Bao S. Li Y. Wu C. Liu H. Liu D. Shao J. Peng X. Yang Y. Liu Z. Xiang Y. Zhang F. Silva R.M. Pinkerton K.E. Shen K. Xiao H. Xu S. Wong G.W.K. Chinese Pediatric Novel Coronavirus Study Team SARS-CoV-2 infection in children. N. Engl. J. Med. 2020 382 17 1663 1665 10.1056/NEJMc2005073 32187458
    [Google Scholar]
  8. Belay E.D. Abrams J. Oster M.E. Giovanni J. Pierce T. Meng L. Prezzato E. Balachandran N. Openshaw J.J. Rosen H.E. Kim M. Richardson G. Hand J. Tobin-D’Angelo M. Wilson S. Hartley A. Jones C. Kolsin J. Mohamed H. Colles Z. Hammett T. Patel P. Stierman B. Campbell A.P. Godfred-Cato S. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr. 2021 175 8 837 845 10.1001/jamapediatrics.2021.0630 33821923
    [Google Scholar]
  9. Alsaied T. Tremoulet A.H. Burns J.C. Saidi A. Dionne A. Lang S.M. Newburger J.W. de Ferranti S. Friedman K.G. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation 2021 143 1 78 88 10.1161/CIRCULATIONAHA.120.049836 33166178
    [Google Scholar]
  10. Abi Nassif T. Cardiac manifestations in COVID-19 patients: A focus on the pediatric population. Can. J. Infect. Dis. Med. Microbiol. 2021
    [Google Scholar]
  11. U.S. Department of Health and Human Services Fact Sheet: End of the COVID-19 Public Health Emergency. 2023 Available from: https://www.hhs.gov/about/news/2023/05/09/fact-sheet-end-of-the-covid-19-public-health-emergency.html
  12. CDC updates and simplifies respiratory virus recommendations. 2024 Available from: https://www.cdc.gov/media/releases/2024/p0301-respiratory-virus.html
  13. Zhu F. Ang J.Y. COVID-19 infection in children: Diagnosis and management. Curr. Infect. Dis. Rep. 2022 24 4 51 62 10.1007/s11908‑022‑00779‑0 35431658
    [Google Scholar]
  14. Heching H.J. Goyal A. Harvey B. Malloy-Walton L. Follansbee C. Mcintosh A. Forsha D. Electrocardiographic changes in non-hospitalised children with COVID-19. Cardiol. Young 2022 32 12 1910 1916 10.1017/S1047951121005138 34986922
    [Google Scholar]
  15. Disease Control and Prevention Disease control and prevention, information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). 2021 Available from: https://www.cdc.gov/mis/mis-c/hcp/index.html
  16. Stein M. Ashkenazi-Hoffnung L. Greenberg D. Dalal I. Livni G. Chapnick G. Stein-Zamir C. Ashkenazi S. Hecht-Sagie L. Grossman Z. The burden of COVID-19 in children and its prevention by vaccination: A joint statement of the israeli pediatric association and the israeli society for pediatric infectious diseases. Vaccines 2022 10 1 81 10.3390/vaccines10010081 35062742
    [Google Scholar]
  17. Soleimani A. Soleimani Z. Presentation and outcome of congenital heart disease during Covid-19 pandemic: A review. Curr. Probl. Cardiol. 2022 47 1 100905 10.1016/j.cpcardiol.2021.100905 34172316
    [Google Scholar]
  18. Haji Esmaeil Memar E. Pourakbari B. Gorgi M. Sharifzadeh Ekbatani M. Navaeian A. Khodabandeh M. Mahmoudi S. Mamishi S. COVID-19 and congenital heart disease: A case series of nine children. World J. Pediatr. 2021 17 1 71 78 10.1007/s12519‑020‑00397‑7 33387256
    [Google Scholar]
  19. Organization W.H. Tracking SARS-CoV-2 variants. 2024 Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants
  20. Woodruff R.C. Campbell A.P. Taylor C.A. Chai S.J. Kawasaki B. Meek J. Anderson E.J. Weigel A. Monroe M.L. Reeg L. Bye E. Sosin D.M. Muse A. Bennett N.M. Billing L.M. Sutton M. Talbot H.K. McCaffrey K. Pham H. Patel K. Whitaker M. McMorrow M. Havers F. Risk factors for severe COVID-19 in children. Pediatrics 2022 149 1 e2021053418 10.1542/peds.2021‑053418 34935038
    [Google Scholar]
  21. Feldstein L.R. Tenforde M.W. Friedman K.G. Newhams M. Rose E.B. Dapul H. Soma V.L. Maddux A.B. Mourani P.M. Bowens C. Maamari M. Hall M.W. Riggs B.J. Giuliano J.S. Jr Singh A.R. Li S. Kong M. Schuster J.E. McLaughlin G.E. Schwartz S.P. Walker T.C. Loftis L.L. Hobbs C.V. Halasa N.B. Doymaz S. Babbitt C.J. Hume J.R. Gertz S.J. Irby K. Clouser K.N. Cvijanovich N.Z. Bradford T.T. Smith L.S. Heidemann S.M. Zackai S.P. Wellnitz K. Nofziger R.A. Horwitz S.M. Carroll R.W. Rowan C.M. Tarquinio K.M. Mack E.H. Fitzgerald J.C. Coates B.M. Jackson A.M. Young C.C. Son M.B.F. Patel M.M. Newburger J.W. Randolph A.G. Overcoming COVID-19 Investigators Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021 325 11 1074 1087 10.1001/jama.2021.2091 33625505
    [Google Scholar]
  22. Vasichkina E. Alekseeva D. Kudryavtsev I. Glushkova A. Starshinova A.Y. Malkova A. Kudlay D. Starshinova A. COVID-19 heart lesions in children: Clinical, diagnostic and immunological changes. Int. J. Mol. Sci. 2023 24 2 1147 10.3390/ijms24021147 36674665
    [Google Scholar]
  23. Crawford R.L. Bolin E.H. Prodhan P. Renno M.S. Knecht K.R. Variable presentation of COVID-19 in pediatric patients. Pediatr. Infect. Dis. J. 2021 40 2 e88 e90 10.1097/INF.0000000000002974 33433162
    [Google Scholar]
  24. Dionne A. Friedman K.G. Young C.C. Newhams M.M. Kucukak S. Jackson A.M. Fitzgerald J.C. Smallcomb L.S. Heidemann S. McLaughlin G.E. Irby K. Bradford T.T. Horwitz S.M. Loftis L.L. Soma V.L. Rowan C.M. Kong M. Halasa N.B. Tarquinio K.M. Schwarz A.J. Hume J.R. Gertz S.J. Clouser K.N. Carroll C.L. Wellnitz K. Cullimore M.L. Doymaz S. Levy E.R. Typpo K.V. Lansell A.N. Butler A.D. Kuebler J.D. Zambrano L.D. Campbell A.P. Patel M.M. Randolph A.G. Newburger J.W. Overcoming COVID-19 Investigators Tachyarrhythmias during hospitalization for covid-19 or multisystem inflammatory syndrome in children and adolescents. J. Am. Heart Assoc. 2022 11 20 e025915 10.1161/JAHA.122.025915 36250670
    [Google Scholar]
  25. Nirmatrelvir and ritonavir: Pediatric drug information. Available from: https://www.uptodate.com/contents/nirmatrelvir-and-ritonavir-pediatric-drug-information?search=sars%20cov%202%20treatment&topicRef=134695&source=see_link
  26. Andrews H.S. Herman J.D. Gandhi R.T. Treatments for COVID-19. Annu. Rev. Med. 2024 75 1 145 157 10.1146/annurev‑med‑052422‑020316 37722709
    [Google Scholar]
  27. Riphagen S. Gomez X. Gonzalez-Martinez C. Wilkinson N. Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020 395 10237 1607 1608 10.1016/S0140‑6736(20)31094‑1 32386565
    [Google Scholar]
  28. Centers for disease control and prevention health advisory: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (covid-19). 2020 Available from: https://emergency.cdc.gov/coca/calls/2020/callinfo_051920.asp
  29. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. Available from: https://www.cdc.gov/mis-c/cases/index.html 2020
  30. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). Available from: https://www.cdc.gov/mis/mis-c/hcp_cstecdc/index.html
  31. Son M.B.F. Burns J.C. Newburger J.W. A new definition for multisystem inflammatory syndrome in children. Pediatrics 2023 151 3 e2022060302 10.1542/peds.2022‑060302 36624565
    [Google Scholar]
  32. Miller A.D. Zambrano L.D. Yousaf A.R. Abrams J.Y. Meng L. Wu M.J. Melgar M. Oster M.E. Godfred Cato S.E. Belay E.D. Campbell A.P. MIS-C Surveillance Authorship Group Multisystem inflammatory syndrome in children-united states, february 2020-July 2021. Clin. Infect. Dis. 2022 75 1 e1165 e1175 10.1093/cid/ciab1007 34864955
    [Google Scholar]
  33. Miller A.D. Yousaf A.R. Bornstein E. Wu M.J. Lindsey K. Melgar M. Oster M.E. Zambrano L.D. Campbell A.P. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus 2 (sars-cov-2) delta and omicron variant circulation—united states, july 2021–january 2022. Clin. Infect. Dis. 2022 75 Suppl. 2 S303 S307 10.1093/cid/ciac471 35684958
    [Google Scholar]
  34. Dufort E.M. Koumans E.H. Chow E.J. Rosenthal E.M. Muse A. Rowlands J. Barranco M.A. Maxted A.M. Rosenberg E.S. Easton D. Udo T. Kumar J. Pulver W. Smith L. Hutton B. Blog D. Zucker H. Multisystem inflammatory syndrome in children in new york state. N. Engl. J. Med. 2020 383 4 347 358 10.1056/NEJMoa2021756 32598830
    [Google Scholar]
  35. Feldstein L.R. Rose E.B. Horwitz S.M. Collins J.P. Newhams M.M. Son M.B.F. Newburger J.W. Kleinman L.C. Heidemann S.M. Martin A.A. Singh A.R. Li S. Tarquinio K.M. Jaggi P. Oster M.E. Zackai S.P. Gillen J. Ratner A.J. Walsh R.F. Fitzgerald J.C. Keenaghan M.A. Alharash H. Doymaz S. Clouser K.N. Giuliano J.S. Jr Gupta A. Parker R.M. Maddux A.B. Havalad V. Ramsingh S. Bukulmez H. Bradford T.T. Smith L.S. Tenforde M.W. Carroll C.L. Riggs B.J. Gertz S.J. Daube A. Lansell A. Coronado Munoz A. Hobbs C.V. Marohn K.L. Halasa N.B. Patel M.M. Randolph A.G. Overcoming COVID-19 Investigators CDC COVID-19 Response Team Multisystem inflammatory syndrome in u.s. children and adolescents. N. Engl. J. Med. 2020 383 4 334 346 10.1056/NEJMoa2021680 32598831
    [Google Scholar]
  36. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. 2024 Available from: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance
  37. Laird-Gion J. Dionne A. Gauvreau K. Baker A. Day-Lewis M. de Ferranti S. Friedman K. Khan N. Mahanta S. Son M.B. Sperotto F. Newburger J.W. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children. Eur. J. Pediatr. 2023 182 6 2865 2872 10.1007/s00431‑023‑04968‑4 37055630
    [Google Scholar]
  38. Dove M.L. Jaggi P. Kelleman M. Abuali M. Ang J.Y. Ballan W. Basu S.K. Campbell M.J. Chikkabyrappa S.M. Choueiter N.F. Clouser K.N. Corwin D. Edwards A. Gertz S.J. Ghassemzadeh R. Jarrah R.J. Katz S.E. Knutson S.M. Kuebler J.D. Lighter J. Mikesell C. Mongkolrattanothai K. Morton T. Nakra N.A. Olivero R. Osborne C.M. Panesar L.E. Parsons S. Patel R.M. Schuette J. Thacker D. Tremoulet A.H. Vidwan N.K. Oster M.E. Multisystem inflammatory syndrome in children: Survey of protocols for early hospital evaluation and management. J. Pediatr. 2021 229 33 40 10.1016/j.jpeds.2020.10.026 33075369
    [Google Scholar]
  39. Jain S. He F. Brown K. Burns J.C. Tremoulet A.H. Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial. Contemp. Clin. Trials Commun. 2023 32 101060 10.1016/j.conctc.2023.101060 36694613
    [Google Scholar]
  40. Cole L.D. Osborne C.M. Silveira L.J. Rao S. Lockwood J.M. Kunkel M.J. MacBrayne C.E. Heizer H.R. Anderson M.S. Jone P.N. Dominguez S.R. IVIG compared with ivig plus infliximab in multisystem inflammatory syndrome in children. Pediatrics 2021 148 6 e2021052702 10.1542/peds.2021‑052702 34548377
    [Google Scholar]
  41. Marshall M. Ferguson I.D. Lewis P. Jaggi P. Gagliardo C. Collins J.S. Shaughnessy R. Caron R. Fuss C. Corbin K.J.E. Emuren L. Faherty E. Hall E.K. Di Pentima C. Oster M.E. Paintsil E. Siddiqui S. Timchak D.M. Guzman-Cottrill J.A. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics 2021 148 3 e2021052478 10.1542/peds.2021‑052478 34088762
    [Google Scholar]
  42. Patone M. Mei X.W. Handunnetthi L. Dixon S. Zaccardi F. Shankar-Hari M. Watkinson P. Khunti K. Harnden A. Coupland C.A.C. Channon K.M. Mills N.L. Sheikh A. Hippisley-Cox J. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation 2022 146 10 743 754 10.1161/CIRCULATIONAHA.122.059970 35993236
    [Google Scholar]
  43. Pillay J. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following COVID-19 vaccination: Living evidence syntheses and review. BMJ 2022 378 10.1136/bmj‑2021‑069445
    [Google Scholar]
  44. Fatima M. Khan M.H.A. Ali M.S. Osama M. Cheema H.A. Ahmed A. Nisar A. Murad M.W. Farooq H. Aemaz Ur Rehman M. Swed S. Akbar U.A. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review. Clin. Cardiol. 2023 46 3 243 259 10.1002/clc.23965 36594165
    [Google Scholar]
  45. Shay D.K. Shimabukuro T.T. DeStefano F. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA Cardiol. 2021 6 10 1115 1117 10.1001/jamacardio.2021.2821 34185047
    [Google Scholar]
  46. Truong D.T. Dionne A. Muniz J.C. McHugh K.E. Portman M.A. Lambert L.M. Thacker D. Elias M.D. Li J.S. Toro-Salazar O.H. Anderson B.R. Atz A.M. Bohun C.M. Campbell M.J. Chrisant M. D’Addese L. Dummer K.B. Forsha D. Frank L.H. Frosch O.H. Gelehrter S.K. Giglia T.M. Hebson C. Jain S.S. Johnston P. Krishnan A. Lombardi K.C. McCrindle B.W. Mitchell E.C. Miyata K. Mizzi T. Parker R.M. Patel J.K. Ronai C. Sabati A.A. Schauer J. Sexson Tejtel S.K. Shea J.R. Shekerdemian L.S. Srivastava S. Votava-Smith J.K. White S. Newburger J.W. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: Suspected myocarditis after COVID-19 vaccination. Circulation 2022 145 5 345 356 10.1161/CIRCULATIONAHA.121.056583 34865500
    [Google Scholar]
  47. Hause A.M. Marquez P. Zhang B. Su J.R. Myers T.R. Gee J. Panchanathan S.S. Thompson D. Shimabukuro T.T. Shay D.K. Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among children aged 5–11 years — united states, october 12–january 1, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023 72 2 39 43 10.15585/mmwr.mm7202a5 36634021
    [Google Scholar]
  48. Elias M.D. Truong D.T. Oster M.E. Trachtenberg F.L. Mu X. Jone P.N. Mitchell E.C. Dummer K.B. Sexson Tejtel S.K. Osakwe O. Thacker D. Su J.A. Bradford T.T. Burns K.M. Campbell M.J. Connors T.J. D’Addese L. Forsha D. Frosch O.H. Giglia T.M. Goodell L.R. Handler S.S. Hasbani K. Hebson C. Krishnan A. Lang S.M. McCrindle B.W. McHugh K.E. Morgan L.M. Payne R.M. Sabati A. Sagiv E. Sanil Y. Serrano F. Newburger J.W. Dionne A. Pearson G. Pemberton V. Egerson D.A. Mahony L. Miller J. Hayes K. Crosby-Thompson A. Amarnath A. Ambrosoli J. Artis C. Rubio K. Kinhikar C. Marshall A. Mbiydzenyuy D. Kazlova V. Hu C. Eyob L. Slayton B. DiStefano L. Honig J. Bowie T. Nero R. Birmingham E. Rowe R. Joyce M. Gallagher C. Bowman D. Zhang M. Mooney A. Dragulescu A. Lam C. Yeung R. Gamulka B. Bainton J. Rolland M. Walter P. Mahanta S. Giorgio T. Khan N. Baker A. Buckley L.J. Jones J. Watson L.T. Clarke A. Leek T-S-A. Orav G. Morrison T. Lupton K. Sylvester D. Albizem D. Lanzilotta K. Marks G. Johnson M. Bickford M. Lambert L. Fagatele L. Curless A. Russell M. Doman T. Almaguer M. Dugan L. Rathge K. Seibert E. Stumpf M. Howell J. Patel J. Mitscher G. Burnett M. Sanders-Lewis K. Evans B. Mahle W.T. Kochilas L. Rudow M. Gentry S. Le K. Taylor C. Shekerdemian L. Moussi E. Pena S. Pignatelli R. Garuba O. Liu A. Anderson B. Sanchez C. Martyrosyan K. Szmuszkovicz J.R. Cheng A.L. Mohandas S. Votava-Smith J.K. Wang S. Wong P.C. Sharma K. Martinez M. Mohazabnia P. Rojas W. Block J. Cole R. Maldonado J. Srivastava S. Prospero C. Zadokar V. Williams E. Carr M. Van’t Hof K. Sullivan C. Portman M.A. Kajimoto H. Nair D.G. Beckley M.A. Pancheri J. Crane K. Harahsheh A. Berul C. Olivieri L. Haverty M. Fetch A. Schott C. Litt S. Nelson J. Hite M. Glassmeyer I. Nowlen T. Herzberg A. Stack S. Porche J. Park S. Johnson A. Shakti D. Parnell A.S. Weiland M.D. Parker P. Kertis J.A. Hobbs C.V. Howard C.M. Savadkar S. Worrell A.E. Barr M.R. Williams H. Gordy D. Vemula P. White Z. Morato J.G.S. Tyler S. Hock K. Sykes M. Owada C. Lemus Rangel M. Macias I. Singh G. Aggarwal S. Williams-Farr C. Sullivan N. Almasnaah A. Undyala V. Hannah B. McCall M. Strelow J. Downey R. Shaffer K. Castleberry C. Pomeroy L. Amsellem R. Shamailova O. Johnston M. Muniz J.C. Chang M. Shea R. Davis M. Chrisant M. Katz D. Barton N. Alaby D. Smith P. Friedman K. Sperotto F. Marcus E. Ferreira R. McGeoghegan P. Taylor M. Germann J. Powell A. Mackie A. Gobburu J. Hunsberger S. McQuillen P. Spaeder M. Atkins D. Broberg C. Driscoll D.J. Evans F. Hunsberger S.A. Johnson L-M. Knight T.J. Lipkin P. Saul J.P. Pediatric Heart Network MUSIC Study Investigators Examination of adverse reactions after covid-19 vaccination among patients with a history of multisystem inflammatory syndrome in children. JAMA Netw. Open 2023 6 1 e2248987 10.1001/jamanetworkopen.2022.48987 36595296
    [Google Scholar]
  49. Son M.B.F. Murray N. Friedman K. Young C.C. Newhams M.M. Feldstein L.R. Loftis L.L. Tarquinio K.M. Singh A.R. Heidemann S.M. Soma V.L. Riggs B.J. Fitzgerald J.C. Kong M. Doymaz S. Giuliano J.S. Jr Keenaghan M.A. Hume J.R. Hobbs C.V. Schuster J.E. Clouser K.N. Hall M.W. Smith L.S. Horwitz S.M. Schwartz S.P. Irby K. Bradford T.T. Maddux A.B. Babbitt C.J. Rowan C.M. McLaughlin G.E. Yager P.H. Maamari M. Mack E.H. Carroll C.L. Montgomery V.L. Halasa N.B. Cvijanovich N.Z. Coates B.M. Rose C.E. Newburger J.W. Patel M.M. Randolph A.G. Overcoming COVID-19 Investigators Multisystem inflammatory syndrome in children — initial therapy and outcomes. N. Engl. J. Med. 2021 385 1 23 34 10.1056/NEJMoa2102605 34133855
    [Google Scholar]
  50. Zaffanello M. Piacentini G. Nosetti L. Ganzarolli S. Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thromb. Res. 2021 205 92 98 10.1016/j.thromres.2021.07.011 34293539
    [Google Scholar]
  51. Oster M.E. Shay D.K. Su J.R. Gee J. Creech C.B. Broder K.R. Edwards K. Soslow J.H. Dendy J.M. Schlaudecker E. Lang S.M. Barnett E.D. Ruberg F.L. Smith M.J. Campbell M.J. Lopes R.D. Sperling L.S. Baumblatt J.A. Thompson D.L. Marquez P.L. Strid P. Woo J. Pugsley R. Reagan-Steiner S. DeStefano F. Shimabukuro T.T. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA 2022 327 4 331 340 10.1001/jama.2021.24110 35076665
    [Google Scholar]
  52. Chin S.E. Bhavsar S.M. Corson A. Ghersin Z.J. Kim H.S. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination. Pediatr. Cardiol. 2022 43 3 483 488 10.1007/s00246‑022‑02851‑x 35258639
    [Google Scholar]
  53. Kohli U. mRNA coronavirus disease 2019 vaccine-associated myopericarditis in adolescents: A survey study. J. Pediatr. 2022 243 208 213
    [Google Scholar]
  54. Nafilyan V. Bermingham C.R. Ward I.L. Morgan J. Zaccardi F. Khunti K. Stanborough J. Banerjee A. Doidge J.C. Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England. Nat. Commun. 2023 14 1 1541 10.1038/s41467‑023‑36494‑0 36973247
    [Google Scholar]
  55. Shahid R. Tang W.H.W. Klein A.L. Kwon D. Amdani S. Is the mRNA COVID-19 vaccine safe in patients with a prior history of myocarditis? J. Card. Fail. 2023 29 1 108 111 10.1016/j.cardfail.2022.06.011 35842104
    [Google Scholar]
  56. Puntmann V.O. Carerj M.L. Wieters I. Fahim M. Arendt C. Hoffmann J. Shchendrygina A. Escher F. Vasa-Nicotera M. Zeiher A.M. Vehreschild M. Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 5 11 1265 1273 10.1001/jamacardio.2020.3557 32730619
    [Google Scholar]
  57. Huang L. Zhao P. Tang D. Zhu T. Han R. Zhan C. Liu W. Zeng H. Tao Q. Xia L. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging 2020 13 11 2330 2339 10.1016/j.jcmg.2020.05.004 32763118
    [Google Scholar]
  58. Phelan D. Kim J.H. Chung E.H. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020 5 10 1085 1086 10.1001/jamacardio.2020.2136 32402054
    [Google Scholar]
  59. Schellhorn P. Klingel K. Burgstahler C. Return to sports after COVID-19 infection. Oxford University Press 2020 10.1093/eurheartj/ehaa448
    [Google Scholar]
  60. Baggish A.L. Levine B.D. Icarus and sports after COVID 19: too close to the sun? Circulation 2020 142 7 615 617 10.1161/CIRCULATIONAHA.120.048335 32516032
    [Google Scholar]
  61. Daniels C.J. Rajpal S. Greenshields J.T. Rosenthal G.L. Chung E.H. Terrin M. Jeudy J. Mattson S.E. Law I.H. Borchers J. Kovacs R. Kovan J. Rifat S.F. Albrecht J. Bento A.I. Albers L. Bernhardt D. Day C. Hecht S. Hipskind A. Mjaanes J. Olson D. Rooks Y.L. Somers E.C. Tong M.S. Wisinski J. Womack J. Esopenko C. Kratochvil C.J. Rink L.D. Simonetti O. Zareba K. Bhatti S. Addison D. Obarski T. Daoud E. Granger M. Smart S. Mayercin-Johnson J. Subramanian P. Glitt J. Mitchell D. Chumita R. Mumford A. Garcia A. Garris L. Liu H. Hatfield B. Zhang Y. Boersma D. Schlader Z. Goodwin S. Port N. Zuidema T. Maldonado J. Eckhardt L. Reeder S. Baker M. Sebastianelli W. Wadlinger R. Millard R. Bosha P. Sunday H. Steele D. Chaudhry A. Smith S. Pfeiffer M. Kellerman J. Billy G. Krystofiak J. Eimer M. Big Ten COVID-19 Cardiac Registry Investigators Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021 6 9 1078 1087 10.1001/jamacardio.2021.2065 34042947
    [Google Scholar]
  62. Rajpal S. Tong M.S. Borchers J. Zareba K.M. Obarski T.P. Simonetti O.P. Daniels C.J. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021 6 1 116 118 32915194
    [Google Scholar]
  63. Sharma C.G.B. Roger S. COVID-19, myocarditis, and cardiac MRI in athletes: Distinguishing signal from noise. 2021 Available from: https://www.acc.org/latest-in-cardiology/articles/2021/09/28/18/07/covid-19-myocarditis-and-cardiac-mri-in-athletes
  64. Artico J. Shiwani H. Moon J.C. Gorecka M. McCann G.P. Roditi G. Morrow A. Mangion K. Lukaschuk E. Shanmuganathan M. Miller C.A. Chiribiri A. Prasad S.K. Adam R.D. Singh T. Bucciarelli-Ducci C. Dawson D. Knight D. Fontana M. Manisty C. Treibel T.A. Levelt E. Arnold R. Macfarlane P.W. Young R. McConnachie A. Neubauer S. Piechnik S.K. Davies R.H. Ferreira V.M. Dweck M.R. Berry C. Greenwood J.P. OxAMI (Oxford Acute Myocardial Infarction Study) Investigators; COVID-HEART Investigators† Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: A prospective, multicenter, observational study. Circulation 2023 147 5 364 374 10.1161/CIRCULATIONAHA.122.060632 36705028
    [Google Scholar]
  65. Kim J.H. Levine B.D. Phelan D. Emery M.S. Martinez M.W. Chung E.H. Thompson P.D. Baggish A.L. Coronavirus disease 2019 and the athletic heart: Emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021 6 2 219 227 10.1001/jamacardio.2020.5890 33104154
    [Google Scholar]
  66. Gluckman T.J. Bhave N.M. Allen L.A. Chung E.H. Spatz E.S. Ammirati E. Baggish A.L. Bozkurt B. Cornwell W.K. III Harmon K.G. Kim J.H. Lala A. Levine B.D. Martinez M.W. Onuma O. Phelan D. Puntmann V.O. Rajpal S. Taub P.R. Verma A.K. Writing Committee 2022 ACC expert consensus decision pathway on cardiovascular sequelae of covid-19 in adults: Myocarditis and other myocardial involvement, post-acute sequelae of sars-cov-2 infection, and return to play. J. Am. Coll. Cardiol. 2022 79 17 1717 1756 10.1016/j.jacc.2022.02.003 35307156
    [Google Scholar]
  67. Dean P.N. Jackson L. Paridon S. Returning to play after coronavirus infection: Pediatric Cardiologists’ perspective. Am Coll Cardiol 2020 1 6
    [Google Scholar]
  68. D’Ascenzi F. Castelletti S. Adami P.E. Cavarretta E. Sanz-de la Garza M. Maestrini V. Biffi A. Kantor P. Pieles G. Verhagen E. Tiberi M. Hanssen H. Papadakis M. Niebauer J. Halle M. Cardiac screening prior to return to play after SARS-CoV-2 infection: Focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology. Eur. J. Prev. Cardiol. 2022 29 16 2120 2124 10.1093/eurjpc/zwac180 36059208
    [Google Scholar]
  69. Salman D. Returning to physical activity after COVID-19. BMJ 2021 372 10.1136/bmj.m4721
    [Google Scholar]
  70. American Academy of Pediatrics COVID-19 interim guidance: Return to sports and physical activity. 2022 Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-interim-guidance-return-to-sports/
  71. Maron B.J. Udelson J.E. Bonow R.O. Nishimura R.A. Ackerman M.J. Estes N.A. III Cooper L.T. Jr Link M.S. Maron M.S. American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 3: Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: A scientific statement from the American Heart Association and American College of Cardiology. Circulation 2015 132 22 e273 e280 26621644
    [Google Scholar]
  72. Drezner J.A. Heinz W.M. Asif I.M. Batten C.G. Fields K.B. Raukar N.P. Valentine V.D. Walter K.D. Cardiopulmonary considerations for high school student-athletes during the COVID-19 pandemic: NFHS-AMSSM guidance statement. Sports Health 2020 12 5 459 461 10.1177/1941738120941490 32640879
    [Google Scholar]
  73. Elliott N. Martin R. Heron N. Elliott J. Grimstead D. Biswas A. Infographic. Graduated return to play guidance following COVID-19 infection. Br. J. Sports Med. 2020 54 19 1174 1175 10.1136/bjsports‑2020‑102637 32571796
    [Google Scholar]
  74. Petek B.J. Moulson N. Drezner J.A. Harmon K.G. Kliethermes S.A. Churchill T.W. Patel M.R. Baggish A.L. Asif I.M. Baggish A.L. Borchers J. Drezner J.A. Edenfield K.M. Emery M.S. Goerl K. Hainline B. Harmon K.G. Jone P-N. Kim J.H. Kliethermes S. Kraus W.E. Lampert R. Leiszler M. Levine B.D. Martinez M.W. Moulson N. O’Connor F.G. Patel M.R. Petek B.J. Phelan D. Rink L.D. Taylor H.A. Ade C. Aiyer A. Alfadhli J. Amaradio C. Anderson S. Arlis-Mayor S. Aubry J.S. Austin A. Balcik B.J. Beaver T. Benitez N. Berkstresser B. Best T.M. Bohon T. Bonnet J.P. Boyington E. Bray J. Bryant J. Bytomski J. Carnahan S. Chamberlain R. Charters S. Chill N. Clark D.E. Comeau D. Cook L.E. Corey D. Costa A. Crowther M. Dalia T. Davidson C. Davitt K. Maurice A.D.S. Dean P.N. Dendy J.M. DeZenzo K. Dimitris C. Doperak J. Duffaut C. Fafara C. Fahy K. Ferderber J. Finn M. Fish F.A. Fitch R.W. Galante A. Gerlt T. Gest A. Gilson C. Goldberger J. Goldman J. Groezinger E. Guin J.R. Halseth H. Hare J. Harness B. Hatamiya N. Haylett J. Hazen N. Hughes S.G. Hiroi Y. Hockenbrock A. Honsvall A. Hopp J. Howard J. Huba S. Husaini M. Huston L. Hwang C. Irvin L. Iven V.G. Jones R. Joyce D. Karlson K. Kent J. Klein C.F. Klenck C. Kirk M. Knight J. Knippa L. Knutson M. Kovacs L.E. Kuscher Y. Kussman A. Landreth C. Leu A. Lothian D. Lowery M. Lukjanczuk A. MacKnight J.M. Magee L.M. Magnuson M-L. Mares A.V. Marquez A. McKinley G. Meester S. Meier M. Mellacheruvu P. Miles C. Miller E. Miller H. Mitrani R. Monseau A.J. Moorehead B. Myerburg R.J. Mytyk G. Narver A. Nattiv A. Nur L. Organ B.E. Pendergast M. Pettrone F.A. Pierce J. Poddar S.K. Priestman D. Quinn I. Reifsteck F. Restivo M. Robinson J.B. Roe R. Rosamond T. Rubertino Shearer C. Riveros D. Rueda M. Sakamoto T. Schnebel B. Shah A.B. Shahtaji A. Shannon K. Sheridan-Young P. Soslow J.H. Statuta S.M. Stovak M. Tarsici A. Taylor K.S. Terrell K. Thomason M. Tso J. Vigil D. Wang F. Winningham J. Zorn S.T. ORCCA Investigators Cardiovascular outcomes in collegiate athletes after sars-cov-2 infection: 1-year follow-up from the outcomes registry for cardiac conditions in athletes. Circulation 2022 145 22 1690 1692 10.1161/CIRCULATIONAHA.121.058272 35545946
    [Google Scholar]
  75. Yonts A.Brugler. Pediatric long-covid: A review of the definition, epidemiology, presentation, and pathophysiology. Pediatr. Ann. 2022 51 11 e416 e420 36343180
    [Google Scholar]
  76. Lopez-Leon S. Wegman-Ostrosky T. Perelman C. Sepulveda R. Rebolledo P.A. Cuapio A. Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021 11 1 16144 10.1038/s41598‑021‑95565‑8 34373540
    [Google Scholar]
  77. Piazza M. Di Cicco M. Pecoraro L. Ghezzi M. Peroni D. Comberiati P. Long COVID-19 in children: From the pathogenesis to the biologically plausible roots of the syndrome. Biomolecules 2022 12 4 556 10.3390/biom12040556 35454144
    [Google Scholar]
  78. World Health Organization A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus. 2023 Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1
  79. National Institute for Health and Care Excellence, COVID-19 rapid guideline: Managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE). London 2020
    [Google Scholar]
  80. Xie Y. Xu E. Bowe B. Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022 28 3 583 590 10.1038/s41591‑022‑01689‑3 35132265
    [Google Scholar]
  81. Lopez-Leon S. Wegman-Ostrosky T. Ayuzo del Valle N.C. Perelman C. Sepulveda R. Rebolledo P.A. Cuapio A. Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022 12 1 9950 10.1038/s41598‑022‑13495‑5 35739136
    [Google Scholar]
  82. Kompaniyets L. Bull-Otterson L. Boehmer T.K. Baca S. Alvarez P. Hong K. Hsu J. Harris A.M. Gundlapalli A.V. Saydah S. Post–COVID-19 symptoms and conditions among children and adolescents—United States, March 1, 2020–January 31, 2022. MMWR Morb. Mortal. Wkly. Rep. 2022 71 31 993 999 10.15585/mmwr.mm7131a3 35925799
    [Google Scholar]
  83. Chakraborty A. Johnson J.N. Spagnoli J. Amin N. Mccoy M. Swaminathan N. Yohannan T. Philip R. Long-term cardiovascular outcomes of multisystem inflammatory syndrome in children associated with COVID-19 using an institution based algorithm. Pediatr. Cardiol. 2023 44 2 367 380 10.1007/s00246‑022‑03020‑w 36214896
    [Google Scholar]
  84. Nalbandian A. Sehgal K. Gupta A. Madhavan M.V. McGroder C. Stevens J.S. Cook J.R. Nordvig A.S. Shalev D. Sehrawat T.S. Ahluwalia N. Bikdeli B. Dietz D. Der-Nigoghossian C. Liyanage-Don N. Rosner G.F. Bernstein E.J. Mohan S. Beckley A.A. Seres D.S. Choueiri T.K. Uriel N. Ausiello J.C. Accili D. Freedberg D.E. Baldwin M. Schwartz A. Brodie D. Garcia C.K. Elkind M.S.V. Connors J.M. Bilezikian J.P. Landry D.W. Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021 27 4 601 615 10.1038/s41591‑021‑01283‑z 33753937
    [Google Scholar]
  85. Zheng Y.B. Zeng N. Yuan K. Tian S.S. Yang Y.B. Gao N. Chen X. Zhang A.Y. Kondratiuk A.L. Shi P.P. Zhang F. Sun J. Yue J.L. Lin X. Shi L. Lalvani A. Shi J. Bao Y.P. Lu L. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health 2023 16 5 660 672 10.1016/j.jiph.2023.03.005 36931142
    [Google Scholar]
  86. Trapani G. Verlato G. Bertino E. Maiocco G. Vesentini R. Spadavecchia A. Dessì A. Fanos V. Long COVID-19 in children: An Italian cohort study. Ital. J. Pediatr. 2022 48 1 83 10.1186/s13052‑022‑01282‑x 35659358
    [Google Scholar]
  87. Dani M. Dirksen A. Taraborrelli P. Torocastro M. Panagopoulos D. Sutton R. Lim P.B. Autonomic dysfunction in ‘long COVID’: Rationale, physiology and management strategies. Clin. Med. 2021 21 1 e63 e67 10.7861/clinmed.2020‑0896 33243837
    [Google Scholar]
  88. Blitshteyn S. Whiteson J.H. Abramoff B. Azola A. Bartels M.N. Bhavaraju-Sanka R. Chung T. Fleming T.K. Henning E. Miglis M.G. Sampsel S. Silver J.K. Tosto J. Verduzco-Gutierrez M. Putrino D. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV -2 infection ( PASC ). PM R 2022 14 10 1270 1291 10.1002/pmrj.12894 36169154
    [Google Scholar]
  89. Rowe P.C. Underhill R.A. Friedman K.J. Gurwitt A. Medow M.S. Schwartz M.S. Speight N. Stewart J.M. Vallings R. Rowe K.S. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer. Front Pediatr. 2017 5 121 10.3389/fped.2017.00121 28674681
    [Google Scholar]
  90. Sendzikaite S. Heying R. Milanesi O. Hanseus K. Michel-Behnke I. COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper. Cardiol. Young 2021 31 3 344 351 10.1017/S1047951120005028 33407975
    [Google Scholar]
  91. Strah D.D. Worse hospital outcomes for children and adults with COVID-19 and congenital heart disease. Pediatr. Cardiol. 2021 1 6 34633493
    [Google Scholar]
  92. Malone L.A. Morrow A. Chen Y. Curtis D. de Ferranti S.D. Desai M. Fleming T.K. Giglia T.M. Hall T.A. Henning E. Jadhav S. Johnston A.M. Kathirithamby D.R.C. Kokorelis C. Lachenauer C. Li L. Lin H.C. Locke T. MacArthur C. Mann M. McGrath-Morrow S.A. Ng R. Ohlms L. Risen S. Sadreameli S.C. Sampsel S. Tejtel S.K.S. Silver J.K. Simoneau T. Srouji R. Swami S. Torbey S. Gutierrez M.V. Williams C.N. Zimmerman L.A. Vaz L.E. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of p ostacute sequelae of SARS-CoV -2 infection ( PASC ) in children and adolescents. PM R 2022 14 10 1241 1269 10.1002/pmrj.12890 36169159
    [Google Scholar]
  93. Whiteson J.H. Azola A. Barry J.T. Bartels M.N. Blitshteyn S. Fleming T.K. McCauley M.D. Neal J.D. Pillarisetti J. Sampsel S. Silver J.K. Terzic C.M. Tosto J. Verduzco-Gutierrez M. Putrino D. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV -2 infection ( PASC ). PM R 2022 14 7 855 878 10.1002/pmrj.12859 35657351
    [Google Scholar]
  94. Lahrmann H. Cortelli P. Hilz M. Mathias C.J. Struhal W. Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur. J. Neurol. 2006 13 9 930 936 10.1111/j.1468‑1331.2006.01512.x 16930356
    [Google Scholar]
  95. Sheldon R.S. Grubb B.P. II Olshansky B. Shen W.K. Calkins H. Brignole M. Raj S.R. Krahn A.D. Morillo C.A. Stewart J.M. Sutton R. Sandroni P. Friday K.J. Hachul D.T. Cohen M.I. Lau D.H. Mayuga K.A. Moak J.P. Sandhu R.K. Kanjwal K. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015 12 6 e41 e63 10.1016/j.hrthm.2015.03.029 25980576
    [Google Scholar]
  96. Truong D.T. Trachtenberg F.L. Pearson G.D. Dionne A. Elias M.D. Friedman K. Hayes K.H. Mahony L. McCrindle B.W. Oster M.E. Pemberton V. Powell A.J. Russell M.W. Shekerdemian L.S. Son M.B. Taylor M. Newburger J.W. Dionne A. Elias M.D. Giglia T.M. McHugh K.E. Atz A.M. Pletzer S.A. Truong D.T. Russell M.W. Lang S.M. Payne R.M. Patel J.K. Oster M.E. Shekerdemian L.S. Pignatelli R.H. Sexson K. McCrindle B.W. Lam C. Dragulescu A. Young R.S.M. Gamulka B. Krishnan A. Anderson B.R. Farooqi K.M. Shakti D. Parnell A.S. Osakwe O.J. Sykes M.C. Morgan L. Owada C.Y. Forsha D. Carr M.R. Watanabe K. Portman M.A. Dummer K.B. Burns J.C. Tremoulet A.H. Sharma K. Jone P-N. Heizer M.H.H. Hasbani K. Srivastava S. Mitchell E.C. Hebson C.L. Szmuszkovicz J.R. Wong P.C. Cheng A.L. Votava-Smith J.K. Wang S. Mohandas S. Singh G.K. Aggarwal S. Sanil Y. Bradford T.T. Muniz J.C.G. Li J.S. Campbell M.J. Handler S.S. Shea J.R. Hoffman T.M. Franklin W.J. Sabati A.A. Nowlen T.T. Chrisant M. MUSIC Study Investigators (Supplement 1) The NHLBI study on long-term outcomes after the multisystem inflammatory syndrome in children (MUSIC): Design and objectives. Am. Heart J. 2022 243 43 53 10.1016/j.ahj.2021.08.003 34418362
    [Google Scholar]
/content/journals/cpr/10.2174/0115733963314978240923110844
Loading
Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection
Bentham Science Publishers ; https://doi.org/10.2174/0115733963314978240923110844
/content/journals/cpr/10.2174/0115733963314978240923110844
/content/journals/cpr/10.2174/0115733963314978240923110844
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: MIS-C ; acute SARS-CoV-2 ; long COVID ; Pediatrics ; COVID-19 ; myocarditis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test